Blood Collection Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Collection Site (Venous {Needles and Syringes, Blood collection Tubes, Blood Bags, Others}, Capillary {Lancets, Micro-Container Tubes, Micro-Hematocrit Tubes, Warming Devices, Others}), By Application (Diagnostics, Treatment), By Method (Manual, Automated), By End-use (Hospitals, Blood Banks, Oth
Published Date: November - 2024 | Publisher: MIR | No of Pages: 320 | Industry: Healthcare | Format: Report available in PDF / Excel Format
View Details Buy Now 2890 Download Sample Ask for Discount Request CustomizationBlood Collection Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Collection Site (Venous {Needles and Syringes, Blood collection Tubes, Blood Bags, Others}, Capillary {Lancets, Micro-Container Tubes, Micro-Hematocrit Tubes, Warming Devices, Others}), By Application (Diagnostics, Treatment), By Method (Manual, Automated), By End-use (Hospitals, Blood Banks, Oth
| Forecast Period | 2025-2029 |
| Market Size (2023) | USD 9.26 Billion |
| Market Size (2029) | USD 13.13 Billion |
| CAGR (2024-2029) | 6.07% |
| Fastest Growing Segment | Hospitals |
| Largest Market | North America |
Market Overview
Global Blood Collection Market was valued at USD 9.26 billion in 2023 and is anticipated to project impressive growth in the forecast period with a CAGR of 6.07% through 2029. Blood collection is a crucial component of the healthcare infrastructure, supporting medical treatments, surgeries, trauma care, and disease management. Blood collection involves the voluntary donation or medical extraction of blood from donors. Once collected, the blood undergoes meticulous testing to ensure its safety and compatibility for transfusion. This process is essential for addressing a range of medical scenarios, from surgeries and trauma care to managing chronic conditions and cancer treatments. The blood collection market encompasses a wide range of activities, including blood donation, processing, testing, across the globe. Blood collection includes voluntary blood donations from individuals who are willing to donate their blood to help others in need. These donors can be individuals or organized groups, and they contribute either storage, and distribution. Patients with chronic disorders are treated using blood collection products, notably during difficult surgeries, dialysis, chemotherapy, and organ or tissue transplant operations. Surgeries, both routine and complex, often require blood transfusions to replace blood loss, ensure oxygen transport, and support the body's healing process. Blood collection centers provide the necessary supply for such interventions. The blood collection market is highly influenced by the rise in blood donations whole blood or specific blood components such as red blood cells, platelets, plasma, etc. The blood collection industry is highly regulated by national and international health authorities to ensure the safety and quality of blood and blood products. Regulatory frameworks cover donor eligibility criteria, testing standards, storage conditions, labeling, and transportation.
Key Market Drivers
Growing Demand of Blood in Increasing Chronic Disease Prevalence
The global blood collection market is witnessing a substantial surge in demand, driven significantly by the increasing prevalence of chronic diseases across the globe. Chronic diseases, characterized by their long-lasting and often progressive nature, encompass a wide range of conditions such as cardiovascular diseases, diabetes, cancer, and chronic respiratory diseases. This escalating burden of chronic diseases has a direct and profound impact on the demand for blood collection services and products. According to the World Health Organization (WHO), chronic diseases are the leading cause of mortality worldwide, accounting for approximately 71% of all deaths. The prevalence of chronic diseases is accelerating due to factors like aging populations, urbanization, unhealthy lifestyles, and genetic predisposition. The toll of chronic diseases is felt across all age groups and regions, making their effective management a critical healthcare priority. Many chronic diseases necessitate medical interventions that require blood transfusions. Surgeries, chemotherapy, radiation therapy, and interventions to manage complications often rely on a consistent supply of blood products. Certain chronic diseases, such as anemia in chronic kidney disease or leukemia in cancer patients, can lead to blood-related disorders. These disorders often require regular blood transfusions to manage symptoms and improve patients' quality of life. Chronic diseases can lead to unexpected complications that require emergency interventions, often involving blood transfusions.
Surge in Medical Interventions
Medical advancements have propelled the healthcare industry into new realms of precision and effectiveness. With a rising number of intricate medical interventions being performed worldwide, the demand for blood collection has soared to unprecedented heights. This symbiotic relationship between medical procedures and blood collection plays a pivotal role in ensuring successful outcomes for patients across various medical domains. The increasing prevalence of complex surgeries, organ transplants, and advanced treatments for conditions such as cancer and cardiovascular diseases has given rise to a greater need for blood collection. Blood, a vital source of life-sustaining components, serves multiple functions in modern healthcare. From providing oxygen and nutrients to tissues to facilitating the immune response, blood is an irreplaceable resource. Consequently, medical interventions that involve blood loss necessitate replenishing this crucial fluid to maintain patients' stability and recovery. Transfusions, a key component of medical care, rely heavily on blood collection. Patients undergoing surgeries, particularly those that involve extensive tissue manipulation, require blood transfusions to compensate for blood loss and optimize their chances of recovery. Similarly, individuals undergoing chemotherapy or radiation therapy often experience decreased red blood cell counts, prompting the need for blood transfusions to alleviate anemia and its associated symptoms. Emerging medical fields such as regenerative medicine and gene therapy are also contributing to the surge in blood collection demands. Stem cell transplants, a cornerstone of regenerative medicine, require donors and recipients to undergo thorough blood compatibility testing. Similarly, gene therapy, which holds promising potential in treating genetic disorders, requires meticulous monitoring of patients' blood parameters to ensure the effectiveness and safety of the treatment. As the demand for blood collection continues to rise, the importance of efficient blood management cannot be overstated. Blood banks and donation centers play a pivotal role in ensuring a steady supply of safe and compatible blood products. Additionally, advancements in blood storage and preservation techniques have extended the shelf life of collected blood, allowing healthcare providers more flexibility in managing their inventory.
Rising Technological Innovations
In healthcare, technological innovations have emerged as a significant driver behind the increased demand for blood collection. These innovations, ranging from advanced medical procedures to cutting-edge diagnostic tools, have reshaped the way medical interventions are performed and consequently amplified the necessity for efficient blood collection. One significant technological advancement that has bolstered the demand for blood collection is the rise of minimally invasive surgeries. Procedures once requiring large incisions have been replaced by less intrusive techniques, resulting in reduced patient trauma and quicker recovery times. However, these minimally invasive surgeries can still lead to blood loss, albeit on a smaller scale. Consequently, the demand for blood collection, even in these less invasive procedures, remains crucial to ensure patients' well-being during and after surgery. Additionally, diagnostic technologies have also played a pivotal role in increasing blood collection demand. The advent of precision medicine and personalized diagnostics has led to a greater emphasis on early disease detection and targeted treatments. Biomarker analysis, which often involves blood testing, provides valuable insights into a patient's health status and aids in tailoring treatment plans. As a result, the need for blood collection to facilitate these diagnostic endeavors has grown significantly. The development of advanced treatments such as immunotherapies and gene therapies has further propelled the demand for blood collection. These revolutionary treatments require comprehensive patient profiling and ongoing monitoring of blood parameters to ensure their effectiveness and safety. Blood samples offer valuable information about a patient's immune response, genetic makeup, and overall health, making them indispensable in the management of these novel therapeutic approaches. Telemedicine and remote patient monitoring have also contributed to the surge in blood collection demand. With the ability to remotely track patients' health conditions, healthcare providers can identify potential issues early on and initiate appropriate interventions. Blood samples collected at local clinics or even at patients' homes can be swiftly analyzed, allowing for timely adjustments to treatment plans.
Key Market Challenges
Sustaining Adequate Supply
Ensuring a consistent and sufficient supply of blood remains a paramount challenge for the global blood collection industry. Factors such as seasonal variations, emergencies, and evolving donor demographics can lead to periodic shortages. The industry grapples with fluctuating supplies caused by factors like seasonal shifts and unforeseen emergencies. These variations can result in periodic shortages, straining the availability of critical blood products. Ensuring a reliable supply chain that can swiftly adapt to these dynamics remains a significant challenge, demanding proactive strategies to anticipate and address shortages promptly. Encouraging regular voluntary donations, particularly in regions with cultural or logistical barriers, poses a constant challenge. Maintaining a diverse and committed donor pool to meet the diverse needs of patients and medical procedures requires ongoing efforts and innovative strategies.
Safety and Testing Assurance
Maintaining the safety and quality of donated blood is a critical challenge. Stringent testing protocols are essential to identify infectious agents and ensure compatibility. However, new pathogens and emerging diseases continuously pose challenges to existing testing methods. Striking a balance between stringent testing procedures and the urgent need for timely availability is a complex challenge. Emerging diseases and the appearance of previously unidentified infectious agents necessitate constant vigilance. The adaptability of these pathogens calls for a dynamic approach to testing and safety measures. Blood collection centers must remain agile, prepared to integrate new testing technologies and protocols to effectively screen for these emerging threats. Ensuring donor and recipient safety while mitigating the risk of transmitting infections remains a constant focus for blood collection centers worldwide. Implementing stringent protocols, updating practices in response to emerging threats, and fostering a culture of awareness among donors and staff are pivotal.
Logistics and Distribution Efficiency
Efficient transportation and distribution networks are essential to deliver blood products promptly to medical facilities. However, logistical challenges such as transportation delays, infrastructure limitations, and remote area accessibility hinder timely distribution. Maintaining temperature-controlled conditions to preserve the quality of blood products during transit presents logistical complexities. Maintaining temperature-controlled conditions throughout the journey is paramount to safeguarding the viability and integrity of blood components. Coordinating with multiple stakeholders, including blood banks, hospitals, and transportation providers, requires meticulous planning and continuous monitoring to optimize distribution efficiency. Continuous monitoring, tracking, and analysis of distribution processes are necessary to identify loopholes, enhance performance, and respond to unforeseen challenges. The optimization of distribution efficiency demands a proactive approach that relies on real-time data and feedback loops.
Key Market Trends
Sustainable and Eco-Friendly Solutions
Advances in genomics and personalized medicine are tailoring healthcare treatments to individual patients. This trend is extending to blood collection, with a focus on providing blood products that match patients' genetic profiles. Precise compatibility reduces the risk of adverse reactions, making personalized blood products an emerging area of growth.
Segmental Insights
Collection Site Insights
In 2023, the blood collection market was dominated by the venous segment and accounted for largest share in the market and is anticipated to continue expanding over the coming years. The primary factors influencing the growth of the venous segment are the rise in the demand for medical equipment for detection and diagnosis as well as the number of surgical procedures. The market is also rising as a result of increased knowledge of the benefits of venous blood collection devices over alternative techniques. The major advantage of these devices is that they are comparably painless and just need a minimal amount of blood for the treatment. Due to factors including the lower blood samples requirement, which reduces the danger of contamination, along with the rising research & development to create a wide range of innovative products, the capillary segment is predicted to experience the quickest growth rate during the forecast period.
End-Use Insights
In 2023, t
The growing demand for blood products, such as red blood cells, platelets, and plasma, is driving hospitals to expand their blood collection capabilities. Blood transfusions are essential for various medical treatments, including surgeries, trauma care, cancer therapy, and organ transplants. Therefore, hospitals need to maintain adequate stocks of blood products to meet the needs of their patients, leading to increased collection efforts. Changing regulatory requirements pertaining to blood safety and quality assurance also play a significant role in shaping the hospitals segment of the blood collection market. Healthcare authorities worldwide impose strict regulations to ensure the safety and integrity of blood products, including screening for infectious diseases and proper handling procedures. Hospitals must comply with these regulations, which often necessitate investments in infrastructure, staff training, and quality control measures.
Regional Insights
The North America region has emerged as the frontrunner in the Global Blood Collection Market, solidifying its position through various factors contributing to its sustained growth and dominance. One of the primary drivers fueling this market supremacy is the surge in traffic accidents and the prevalence of chronic diseases across the region. The incidence of traffic accidents in North America has been on the rise in recent years, resulting in a greater demand for blood collection products and services. Traumatic injuries sustained in accidents often necessitate immediate blood transfusions to save lives, thereby driving the need for efficient blood collection and storage systems. The region's aging population, coupled with lifestyle factors, has led to an increased prevalence of chronic diseases such as cardiovascular disorders, cancer, and diabetes. These conditions often require regular blood tests and monitoring, further contributing to the demand for blood collection services.
North America boasts a robust healthcare infrastructure with advanced medical facilities and well-established blood collection centers. The presence of state-of-the-art laboratories equipped with cutting-edge technologies facilitates efficient blood collection, processing, and storage procedures. Additionally, the region is home to several leading players in the blood collection market, fostering a competitive landscape and driving innovation in product development and service offerings. Government initiatives and healthcare policies also play a significant role in shaping the blood collection market in North America. Regulatory bodies such as the Food and Drug Administration (FDA) ensure adherence to stringent quality standards and safety regulations, instilling confidence among consumers and healthcare providers alike. Government-sponsored initiatives aimed at increasing awareness about blood donation and promoting voluntary donation drives contribute to the availability of blood products for medical purposes.
Recent Developments
- In July 2024, the Food and Drug Administration approved Guardant Health's blood test, Shield, for screening colon cancer. While this test is not intended to replace colonoscopies, it has the potential to significantly increase screening rates for colon cancer, which is the second leading cause of cancer-related deaths in the United States.
- In March 2024, BD (Becton, Dickinson and Company) launched the BD Vacutainer® UltraTouch™ Push Button Blood Collection Set in India to minimize patient pain and discomfort while facilitating successful single-prick blood collection. This innovative product features BD RightGauge™ technology, which utilizes a thinner needle for blood collection, and is complemented by BD PentaPoint™ Technology, significantly reducing insertion pain for patients.
- In May 2024, Netherlands-based Vitestro announced positive results from a trial assessing the safety and efficacy of its autonomous blood-drawing device. These results stemmed from the pivotal phase of the Autonomous Blood Drawing Optimization and Performance Testing (ADOPT) study (NCT05878483). The findings from this trial are anticipated to support the device’s approval in Europe by the end of 2024.
- In December 2023, Becton, Dickinson and Company,announced the receipt of 510(k) clearances from the U.S. Food and DrugAdministration (FDA) for an innovative blood collection tool. This device,known as the BD MiniDrawâ„¢ Capillary Blood Collection System, facilitates thecollection of blood samples from a fingerstick, yielding laboratory-qualityresults for a range of commonly requested blood tests. The system offers a lessinvasive alternative to traditional venous blood draws, utilizing capillaryblood obtained from a patient's finger by a trained healthcare professional,thereby eliminating the need for a phlebotomist to draw blood from a vein. Distinguishedby its inventive design, the BD MiniDrawâ„¢ System enables the acquisition ofsamples that deliver laboratory-grade blood test outcomes with only a fractionof the volume typically required for traditional venous collections. Not onlyis this method less invasive compared to conventional venous blood collectiontechniques, but it also enhances patient convenience by expanding access toblood collection services to new locations, such as retail pharmacies. Thisadvancement holds promise for improving the overall patient experience and hasthe potential to revolutionize diagnostic testing procedures. By offering aless intrusive and more accessible means of blood collection, the BD MiniDrawâ„¢Capillary Blood Collection System marks a significant step forward in medicaltechnology, paving the way for enhanced diagnostic capabilities and improvedhealthcare delivery.
Key Market Players
- NIPRO Medical Corporation
- AbbottLaboratories Inc.
- Becton,Dickinson and Company
- TerumoCorporation
- QiagenN.V
- Medtronic plc
- FLMedical s.r.l.
- SARSTEDTAG & Co. KG
- GreinerHolding AG
- HaemoneticsCorporation
| By Collection Site | By Application | By Method | By End-use | By Region |
|
|
|
|
|
FAQ'S
For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:
Within 24 to 48 hrs.
You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email
You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.
Discounts are available.
Hard Copy